Literature DB >> 17245541

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Joanne Kotsopoulos1, Jan Lubinski, Henry T Lynch, Jan Klijn, Parviz Ghadirian, Susan L Neuhausen, Charmaine Kim-Sing, William D Foulkes, Pal Moller, Claudine Isaacs, Susan Domchek, Susan Randall, Kenneth Offit, Nadine Tung, Peter Ainsworth, Ruth Gershoni-Baruch, Andrea Eisen, Mary Daly, Beth Karlan, Howard M Saal, Fergus Couch, Barbara Pasini, Teresa Wagner, Eitan Friedman, Gad Rennert, Charis Eng, Jeffrey Weitzel, Ping Sun, Steven A Narod, J Garber, M Osborne, D Fishman, J McLennan, W McKinnon, S Merajver, H Olsson, D Provencher, B Pasche, G Evans, W S Meschino, E Lemire, A Chudley, D Rayson, C Bellati.   

Abstract

An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case-control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95% CI 0.98-1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.

Entities:  

Mesh:

Year:  2007        PMID: 17245541     DOI: 10.1007/s10549-006-9441-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

Review 1.  What can we learn about disease etiology from case-case analyses? Lessons from breast cancer.

Authors:  María Elena Martínez; Giovanna I Cruz; Abenaa M Brewster; Melissa L Bondy; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-24       Impact factor: 4.254

2.  Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.

Authors:  Patricia G Moorman; Edwin S Iversen; P Kelly Marcom; Jeffrey R Marks; Frances Wang; Eunjung Lee; Giske Ursin; Timothy R Rebbeck; Susan M Domchek; Banu Arun; Lisa Susswein; Claudine Isaacs; Judy E Garber; Kala Visvanathan; Constance A Griffin; Rebecca Sutphen; Jennifer Brzosowicz; Stephen Gruber; Dianne M Finkelstein; Joellen M Schildkraut
Journal:  Breast Cancer Res Treat       Date:  2010-03-23       Impact factor: 4.872

3.  Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.

Authors:  Jenny N Poynter; Bryan Langholz; Joan Largent; Lene Mellemkjaer; Leslie Bernstein; Kathleen E Malone; Charles F Lynch; Ake Borg; Patrick Concannon; Sharon N Teraoka; Shanyan Xue; Anh T Diep; Therese Törngren; Colin B Begg; Marinela Capanu; Robert W Haile; Jonine L Bernstein
Journal:  Cancer Causes Control       Date:  2010-02-04       Impact factor: 2.506

4.  Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.

Authors:  Murray Joseph Casey; Todd A Salzman
Journal:  Linacre Q       Date:  2018-07-20

5.  Hereditary breast and ovarian cancer.

Authors:  Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Oleg Oszurek; Anna Janicka; Jolanta Szymanska-Pasternak; Bohdan Górski; Janusz Menkiszak; Izabella Rzepka-Górska; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

6.  Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Charmaine Kim-Sing; Susan Neuhausen; Rochelle Demsky; William D Foulkes; Parviz Ghadirian; Nadine Tung; Peter Ainsworth; Leigha Senter; Beth Karlan; Andrea Eisen; Charis Eng; Jeffrey Weitzel; Dawna M Gilchrist; Joanne L Blum; Dana Zakalik; Christian Singer; Taya Fallen; Ophira Ginsburg; Tomasz Huzarski; Ping Sun; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

7.  Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Authors:  Julie Lecarpentier; Catherine Noguès; Emmanuelle Mouret-Fourme; Marion Gauthier-Villars; Christine Lasset; Jean-Pierre Fricker; Olivier Caron; Dominique Stoppa-Lyonnet; Pascaline Berthet; Laurence Faivre; Valérie Bonadona; Bruno Buecher; Isabelle Coupier; Laurence Gladieff; Paul Gesta; François Eisinger; Marc Frénay; Elisabeth Luporsi; Alain Lortholary; Chrystelle Colas; Catherine Dugast; Michel Longy; Pascal Pujol; Julie Tinat; Rosette Lidereau; Nadine Andrieu
Journal:  Breast Cancer Res       Date:  2012-07-03       Impact factor: 6.466

Review 8.  Breast cancer and pregnancy: current concepts in diagnosis and treatment.

Authors:  Jennifer K Litton; Richard L Theriault
Journal:  Oncologist       Date:  2010-12-08

9.  Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers.

Authors:  Boyoung Park; John L Hopper; Aung K Win; James G Dowty; Ho Kyung Sung; Choonghyun Ahn; Sung-Won Kim; Min Hyuk Lee; Jihyoun Lee; Jong Won Lee; Eunyoung Kang; Jong-Han Yu; Ku Sang Kim; Byung-In Moon; Wonshik Han; Dong-Young Noh; Sue K Park
Journal:  Oncotarget       Date:  2017-10-31

Review 10.  The breast cancer and the environment research centers: transdisciplinary research on the role of the environment in breast cancer etiology.

Authors:  Robert A Hiatt; Sandra Z Haslam; Janet Osuch
Journal:  Environ Health Perspect       Date:  2009-06-16       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.